Holen Sie sich die Stockscreener-App
2.44
0.41%
-0.01
Handel nachbörslich:
2.46
0.02
+0.82%
Schlusskurs vom Vortag:
$2.45
Offen:
$2.46
24-Stunden-Volumen:
7.11M
Relative Volume:
0.75
Marktkapitalisierung:
$2.31B
Einnahmen:
$1.31M
Nettoeinkommen (Verlust:
$-597.65M
KGV:
-2.5155
EPS:
-0.97
Netto-Cashflow:
$-425.62M
1W Leistung:
-2.79%
1M Leistung:
-10.62%
6M Leistung:
-2.79%
1J Leistung:
-31.27%
1-Tages-Spanne:
$2.42
$2.50
1-Wochen-Bereich:
$2.40
$2.67
52-Wochen-Spanne:
$1.83
$7.48
Immunitybio Inc Stock (IBRX) Company Profile
Firmenname
Immunitybio Inc
Sektor
Branche
Telefon
(844) 696-5235
Adresse
3530 JOHN HOPKINS COURT, SAN DIEGO
Vergleichen Sie IBRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IBRX
Immunitybio Inc
|
2.44 | 2.32B | 1.31M | -597.65M | -425.62M | -0.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.27 | 107.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
474.00 | 64.39B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
579.34 | 61.13B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
834.75 | 52.30B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.31 | 35.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Immunitybio Inc Stock (IBRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-03-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-10 | Eingeleitet | BTIG Research | Buy |
| 2023-05-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-03 | Eingeleitet | Jefferies | Buy |
Immunitybio Inc Aktie (IBRX) Neueste Nachrichten
What drives ImmunityBio Inc stock priceMarket Sentiment Extremes & Exceptional Capital Investment - earlytimes.in
Applying big data sentiment scoring on ImmunityBio Inc.July 2025 Action & Daily Growth Stock Investment Tips - newser.com
Why ImmunityBio Inc. (26CA) stock benefits from AI revolutionWeekly Trade Analysis & Safe Entry Point Identification - newser.com
Will ImmunityBio Inc. rebound enough to break even2025 Dividend Review & Growth-Oriented Investment Plans - newser.com
ImmunityBio Inc. stock retracement – recovery analysisOptions Play & Scalable Portfolio Growth Ideas - newser.com
ImmunityBio Inc. stock trend outlook and recovery path2025 Trading Volume Trends & Real-Time Market Trend Scan - newser.com
Published on: 2025-10-20 12:10:55 - newser.com
Why ImmunityBio Inc. (26CA) stock is a strong analyst pickShare Buyback & Community Consensus Trade Alerts - newser.com
Tick level data insight on ImmunityBio Inc. volatilityQuarterly Trade Report & Precise Buy Zone Tips - newser.com
Will ImmunityBio Inc. stock outperform tech sector in 2025Market Sentiment Report & Technical Entry and Exit Alerts - nchmf.gov.vn
Short interest data insights for ImmunityBio Inc.Trade Entry Report & Fast Moving Trade Plans - newser.com
Is ImmunityBio Inc. stock a buy on dipsWeekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
Will ImmunityBio Inc. stock split again soon2025 Trading Volume Trends & Technical Entry and Exit Tips - nchmf.gov.vn
How ImmunityBio Inc. stock reacts to job market data2025 Market Trends & Weekly Market Pulse Alerts - nchmf.gov.vn
Can machine learning forecast ImmunityBio Inc. recovery2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Institution Moves: Will ImmunityBio Inc. stock outperform tech sector in 20252025 Support & Resistance & Stepwise Swing Trade Plans - nchmf.gov.vn
Discover ImmunityBio And Two Other Growth Stocks With High Insider Ownership - simplywall.st
Is ImmunityBio Inc a good long term investmentResistance Breakout Alerts & Unlock Free Weekly Portfolio Checkups - earlytimes.in
Will ImmunityBio Inc. stock benefit from infrastructure spendingJuly 2025 EndofMonth & Risk Controlled Stock Alerts - newser.com
ImmunityBio, Inc. (IBRX): Investor Outlook With A 311% Potential Upside - DirectorsTalk Interviews
How to recover losses in ImmunityBio Inc. stockJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com
ImmunityBio, Inc.Common Stock (NQ: IBRX - FinancialContent
Why Immunitybio Inc. (IBRX) Soared on Thursday - MSN
ImmunityBio, Inc. (IBRX) Reports Strong Q2 Growth, Eyes Lung Cancer and NMIBC Expansion - MSN
ImmunityBio, Inc. (26CA.F) stock price, news, quote and history - Yahoo
Will EnGene Join The Ranks Of Merck, Ferring, And ImmunityBio In Bladder Cancer Treatment? - RTTNews
IBRX stockholders via consent approve 1.65B common share authorization - Stock Titan
Real time social sentiment graph for ImmunityBio Inc.2025 Pullback Review & Accurate Intraday Trading Signals - newser.com
Evaluating ImmunityBio Inc. with trendline analysis2025 Major Catalysts & Growth Oriented Trading Recommendations - newser.com
Is ImmunityBio Inc. (26CA) stock prepared for digital transitionJuly 2025 Technicals & Smart Allocation Stock Tips - newser.com
Finanzdaten der Immunitybio Inc-Aktie (IBRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.32%
1.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):